CD8A and neoplasm: When the frequency of tumor-specific CD8+ T cells in DLNs of vaccinated tumor-bearing mice decreased to the same level as that of non-vaccinated mice, PD-1Ab21-treated mice still maintained a high frequency of tumor-specific T cells in DLNs, which mostly had the CD62Lhigh phenotype.